Safety and Immunogenicity of a Chlamydia Vaccine CTH522

NCT03926728 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Trachoma

Interventions

BIOLOGICAL: CTH522-CAF01 IM
BIOLOGICAL: CTH522-CAF09b IM
BIOLOGICAL: CTH522 ID
BIOLOGICAL: CTH522 TO
BIOLOGICAL: Placebo (Saline)

Sponsor

Statens Serum Institut

Collaborators

[object Object]